dorsaVi has secured a 12-month renewal of its Department of Defense-funded research with Georgia Southern University, advancing real-time gait optimisation to reduce military training injuries and laying groundwork for its exoskeleton and neuromorphic computing strategy.
- 12-month renewal of DoD-funded military injury prevention study
- Wearable sensors provide real-time gait biofeedback in field conditions
- Research underpins expansion into exoskeleton and robotics markets
- Neuromorphic RRAM chips enable ultra-low power edge AI processing
- No new foundational R&D needed, leveraging existing IP and data
Renewed DoD Contract Targets Stress Fractures in Military Training
dorsaVi Limited (ASX:DVL) has extended its Department of Defense-backed research with Georgia Southern University (GSU) for another year, focusing on reducing stress fractures among military trainees carrying heavy loads during field runs. Stress fractures, often sidelining soldiers for 6 to 18 weeks, represent a costly operational setback, particularly in load-bearing environments where impact forces are high.
The study leverages dorsaVi's wearable sensor technology, which provides real-time gait biofeedback outside controlled labs, enabling trainees to adjust running technique to reduce tibial shock; a key injury risk factor. This approach builds on peer-reviewed research published in Nature (2021) and moves biofeedback from treadmill settings into natural field conditions, a significant step in practical injury prevention.
Advanced Biomechanical Metrics Drive Real-Time Injury Prevention
dorsaVi’s sensors capture high-frequency vertical acceleration data, measuring metrics such as Initial Peak Acceleration (IPA), Ground Reaction Force, Ground Contact Time, Cadence, and Foot Strike Pattern. These parameters are directly linked to injury risk and running performance, providing actionable insights to trainees in real time. The company’s extensive proprietary dataset, accumulated over a decade, continuously refines its AI models, enhancing predictive accuracy and commercial value.
This field-ready platform is uniquely positioned to deliver injury prevention in remote and challenging environments, offering a competitive edge in military and potentially broader applications. The renewal of this contract reinforces dorsaVi’s credibility as a trusted partner in high-stakes government programs and validates its broader “Intelligence at the Ultra-Edge” strategy.
From Injury Prevention to Intelligent Human-Machine Systems
The GSU project serves as a proving ground for dorsaVi’s vision of embedding intelligence directly at the ultra-edge, capturing and processing human movement data in uncontrolled environments. This capability is crucial for emerging human augmentation technologies such as powered exoskeletons, prosthetics, and collaborative robots, which require real-time sensing and adaptive control without reliance on cloud connectivity.
The biomechanical metrics refined in the study; such as cadence asymmetry and peak acceleration; are foundational for synchronising exoskeleton control systems with human gait and fatigue detection. dorsaVi is effectively building the digital nervous system that enables safe, adaptive human-machine interaction.
Strategic Expansion into Exoskeleton and Robotics Markets
dorsaVi is actively exploring commercial opportunities across defence, industrial, healthcare, and aged care sectors, where powered exoskeletons and human-robot collaboration are rapidly gaining traction. The company’s prior work with U.S. fighter pilots and ongoing DoD projects provide meaningful credibility in defence markets, while its fatigue-aware analytics address key safety and regulatory needs in industrial settings.
Crucially, this strategic pivot leverages dorsaVi’s existing sensor platform and clinical IP, requiring no new foundational R&D investment. This capital-efficient approach maximises returns on its neuromorphic semiconductor program and proprietary data assets, positioning the company to capture a first-mover advantage in a market projected to reach billions.
Neuromorphic RRAM Chips Power Ultra-Low Latency Edge Computing
A cornerstone of dorsaVi’s exoskeleton strategy is its RRAM-based neuromorphic semiconductor technology, which mimics brain-like parallel processing to deliver adaptive, low-power AI directly on wearable devices. This architecture eliminates the latency and power constraints of conventional processors and cloud dependency, enabling continuous edge learning and safer human-machine interactions.
The company recently acquired advanced neuromorphic IP from a leading electrical engineering university and is engaging with strategic partners and venture capital in Israel to accelerate commercialisation. This development complements dorsaVi’s hardware advancements, including its modular ultra-edge platform designed for robotics and AI integration, as detailed in its recent modular ultra-edge hardware platform announcement.
By combining its sensor intelligence with neuromorphic RRAM chips, dorsaVi aims to deliver a vertically integrated compute and sensing stack purpose-built for next-generation human augmentation and collaborative robotics, a market segment also highlighted in its neuromorphic sensor platform pivot update.
Bottom Line?
dorsaVi’s DoD-backed research renewal not only advances military injury prevention but also accelerates its transformation into a critical intelligence provider for the burgeoning exoskeleton and robotics sectors.
Questions in the middle?
- Will clinical outcomes from the GSU study demonstrate a measurable reduction in military stress fractures?
- How quickly can dorsaVi translate its neuromorphic RRAM technology into commercial exoskeleton partnerships?
- What competitive advantages will dorsaVi sustain as other players enter the human-robot collaboration market?